RGBPP

distress 10/10 · high distress / dilution risk

$0.00-17%today-95% from 52w high

regenbiopharmainc.comFounded 2012La Mesa, CABiotechnology

Revenue

pre-revenue

Liquidity

$0M

Runway

0.1 yrs

Shares 1y

+374%

Price & events

-53.6% over 6M

CatalystRating changeDilutionFinancingdashed = today

-16.7%

+16.7%

-29.3%

-30.3%

-53.6%

-93.8%

-95.3%

-100.0%

-99.6%

All

Overview

Market Cap: $1.79M
Volume: 22.02K
52 Week Range: $0.00 – $0.07
Total Shares: 511.96M
Float Shares: 465.70M
% Held by Insiders: 0.00%
% Held by Institutions: 0.00%
RVOL: 0.20x
Beta: 0.23

Pipeline · 0 trials · 0 upcoming

Readout	Phase	Drug	Indication	Enroll	Status
No pipeline trials tracked.

Catalyst news & presentations · 0

No catalyst news yet.

Approved drugs (0)

none — clinical-stage

Capital structure — dilution & financing

Shares out: 511,957,643 · 0 offerings/1y · 7 PIPEs

2026-07-158-Kmaterial_agreement
2026-03-048-Kprivate_placement
2026-02-028-Kprivate_placement
2025-11-138-Kprivate_placement
2025-10-038-Kprivate_placement
2025-09-198-Kprivate_placement
2025-08-078-Kprivate_placement

🔒 Positioning — Pro

Short interest / days-to-cover, insider buys & sells.

Upgrade to Pro

🔒 Top holders — Pro

Institutional ownership + quarter-over-quarter accumulation/trimming.

Upgrade to Pro

Wall St ratings

no consensus

no recent rating changes

Competitors

none identified